PURR
NASDAQ
US
Hyperliquid Strategies Inc - Common Stock
Healthcare
· Biotechnology
· IPO Dec 2025
$4.95
▼ $-0.18
(-3.51%)
Vol 3.7M
Beta
0.05
52W
$3–$5
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Similar Stocks
BBOT
BridgeBio Oncology Therapeutics Inc
P/E 212.3
$1.0B
REPL
Replimune Group Inc
$762.5M
DSGN
Design Therapeutics Inc
$534.3M
GYRE
Gyre Therapeutics Inc
P/E 96.5
$641.7M
ALLO
Allogene Therapeutics Inc
$307.9M
PRME
Prime Medicine Inc
$626.4M
OCGN
Ocugen Inc
$421.6M
MDXG
MiMedx Group Inc
P/E 24.6
$1.0B
IRWD
Ironwood Pharmaceuticals Inc
P/E 19.2
$548.2M
PROK
Prokidney Corp
$673.9M
Key Ratios
52W High
$4.65
52W Low
$3.15
$3.15
52-Week Range
$4.65
How does PURR compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
PURR valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
PURR profitability vs Biotechnology peers
ROE
—
▼
0%
below
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
—
▼
0%
below
peers
(-46.7%)
vs Peers
vs Industry
Top tier
PURR financial health vs Biotechnology peers
D/E ratio
—
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
—
▼
0%
below
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.1
▼
95%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
PURR fundamentals radar
PURR
Peer median
Industry
PURR profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio